| MeSH term | MeSH ID | Detail |
|---|---|---|
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Breast Neoplasms | D001943 | 24 associated lipids |
| Neoplasms | D009369 | 13 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Pulmonary Fibrosis | D011658 | 24 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
trichostatin A
Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.
Cross Reference
Introduction
To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with trichostatin A?
trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with trichostatin A
PubChem Associated disorders and diseases
What pathways are associated with trichostatin A
Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with trichostatin A?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with trichostatin A?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with trichostatin A?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with trichostatin A?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with trichostatin A?
Mouse Model
Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).
Xenograft Model
Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).
Cancer Model
Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with trichostatin A
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shi LH et al. | Trichostatin A and nuclear reprogramming of cloned rabbit embryos. | 2008 | J. Anim. Sci. | pmid:18245503 |
| Hou W et al. | Hypoxia-induced deacetylation is required for tetraploid differentiation in response to testicular ischemia-reperfusion (IR) injury. | 2012 Nov-Dec | J. Androl. | pmid:22556385 |
| Fenic I et al. | In vivo application of histone deacetylase inhibitor trichostatin-a impairs murine male meiosis. | 2008 Mar-Apr | J. Androl. | pmid:18046049 |
| Fenic I et al. | In vivo effects of histone-deacetylase inhibitor trichostatin-A on murine spermatogenesis. | 2004 Sep-Oct | J. Androl. | pmid:15292114 |
| Yoshikawa M et al. | Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. | 2007 | J. Am. Soc. Nephrol. | pmid:17135397 |
| Yu Z et al. | Histone deacetylases augment cytokine induction of the iNOS gene. | 2002 | J. Am. Soc. Nephrol. | pmid:12138131 |
| Ren C et al. | Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors. | 2005 | J. Am. Soc. Mass Spectrom. | pmid:16099169 |
| Kudo K et al. | Biosynthetic Origin of the Hydroxamic Acid Moiety of Trichostatin A: Identification of Unprecedented Enzymatic Machinery Involved in Hydroxylamine Transfer. | 2017 | J. Am. Chem. Soc. | pmid:28497964 |
| Milagre I et al. | Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination. | 2010 | J. Alzheimers Dis. | pmid:20930312 |
| Valapour M et al. | Histone deacetylation inhibits IL4 gene expression in T cells. | 2002 | J. Allergy Clin. Immunol. | pmid:11842291 |
| Su RC et al. | Epigenetic regulation of established human type 1 versus type 2 cytokine responses. | 2008 | J. Allergy Clin. Immunol. | pmid:17980413 |
| Simões-Pires CA et al. | Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS. | 2017 | J Vis Exp | pmid:28829415 |
| Azuma R et al. | Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer. | 2018 | J Vis Exp | pmid:29757287 |
| Kimura T et al. | Chromium (VI) inhibits mouse metallothionein-I gene transcription by modifying the transcription potential of the co-activator p300. | 2011 | J Toxicol Sci | pmid:21467744 |
| Albertus DL et al. | AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. | 2008 | J Thorac Oncol | pmid:18978557 |
| Seo SK et al. | Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation. | 2011 | J Thorac Oncol | pmid:21642861 |
| Selinger CI et al. | Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. | 2011 | J Thorac Oncol | pmid:21597389 |
| Kakihana M et al. | Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition. | 2009 | J Thorac Oncol | pmid:20009910 |
| Gavin DP et al. | Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. | 2009 | J Psychiatry Neurosci | pmid:19448855 |
| Gavin DP et al. | Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. | 2009 | J Psychiatr Res | pmid:19187942 |
| Sun G et al. | Insights into the lysine acetylproteome of human sperm. | 2014 | J Proteomics | pmid:25038526 |
| Por ED et al. | Trichostatin A Inhibits Retinal Pigmented Epithelium Activation in an In Vitro Model of Proliferative Vitreoretinopathy. | 2016 | J Ocul Pharmacol Ther | pmid:27494828 |
| Noro R et al. | The anticancer effect of histone deacetylase inhibitors and combination with the cytotoxic agents in lung cancer cells: biological analyses for future clinical application. | 2009 | J Nippon Med Sch | pmid:19305113 |
| Fleiss B et al. | Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury. | 2012 | J Neuroinflammation | pmid:22512781 |
| Suh HS et al. | Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. | 2010 | J Neuroimmune Pharmacol | pmid:20157787 |
| Bence M et al. | Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells. | 2012 | J Neural Transm | pmid:21785940 |
| Wang H et al. | Different effects of histone deacetylase inhibitors nicotinamide and trichostatin A (TSA) in C17.2 neural stem cells. | 2012 | J Neural Transm | pmid:22407380 |
| Klawitter M et al. | Human MMP28 expression is unresponsive to inflammatory stimuli and does not correlate to the grade of intervertebral disc degeneration. | 2011 | J Negat Results Biomed | pmid:21801383 |
| Mastitskaya S and Denecke B | Human spongiosa mesenchymal stem cells fail to generate cardiomyocytes in vitro. | 2009 | J Negat Results Biomed | pmid:19903342 |
| Bar-Nur O et al. | Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. | 2012 | J Mol Cell Biol | pmid:22430918 |
| Zou Y et al. | Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia. | 2012 | J Hematol Oncol | pmid:22747680 |
| Tischler JL et al. | Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors. | 2008 | J Enzyme Inhib Med Chem | pmid:18608778 |
| Duncan HF et al. | Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. | 2012 | J Endod | pmid:22341071 |
| Wu Y et al. | Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway. | 2017 | J Diabetes Res | pmid:28191472 |
| Marengo E et al. | Use of Legendre moments for the fast comparison of two-dimensional polyacrylamide gel electrophoresis maps images. | 2005 | J Chromatogr A | pmid:16301071 |
| Zhao W et al. | A traditional Chinese medicine, Lujiao prescription, as a potential therapy for hypertrophic cardiomyocytes by acting on histone acetylation. | 2015 | J Chin Med Assoc | pmid:25913212 |
| Jang B et al. | Trichostatin A induces apoptosis in oral squamous cell carcinoma cell lines independent of hyperacetylation of histones. | 2018 | J Cancer Res Ther | pmid:30249871 |
| Hutz JE et al. | The multidimensional perturbation value: a single metric to measure similarity and activity of treatments in high-throughput multidimensional screens. | 2013 | J Biomol Screen | pmid:23204073 |
| Chen MH et al. | A new trichostatin analog from Streptomyces sp. CPCC 203909. | 2015 | J Asian Nat Prod Res | pmid:25977996 |
| Schwechter BR et al. | Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. | 2007 | Invest. Ophthalmol. Vis. Sci. | pmid:17525221 |
| Li H et al. | Epigenetic regulation of CXCR4 expression by the ocular microenvironment. | 2013 | Invest. Ophthalmol. Vis. Sci. | pmid:23188729 |
| Kashiwagi Y et al. | Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. | 2010 | Invest. Ophthalmol. Vis. Sci. | pmid:19737884 |
| Crosson CE et al. | Inhibition of histone deacetylase protects the retina from ischemic injury. | 2010 | Invest. Ophthalmol. Vis. Sci. | pmid:20164449 |
| Wood JP et al. | A comparison of differentiation protocols for RGC-5 cells. | 2010 | Invest. Ophthalmol. Vis. Sci. | pmid:20181845 |
| Wallace DM et al. | Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina. | 2006 | Invest. Ophthalmol. Vis. Sci. | pmid:16799012 |
| Wang J et al. | Effect of EGF-induced HDAC6 activation on corneal epithelial wound healing. | 2010 | Invest. Ophthalmol. Vis. Sci. | pmid:20089874 |
| Xie L et al. | Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition. | 2014 | Invest. Ophthalmol. Vis. Sci. | pmid:24994865 |
| Klisovic DD et al. | Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. | 2003 | Invest. Ophthalmol. Vis. Sci. | pmid:12766035 |
| Robertson DM et al. | C-terminal cleavage of DeltaNp63alpha is associated with TSA-induced apoptosis in immortalized corneal epithelial cells. | 2010 | Invest. Ophthalmol. Vis. Sci. | pmid:20375332 |
| Fan J et al. | Inhibition of HDAC2 protects the retina from ischemic injury. | 2013 | Invest. Ophthalmol. Vis. Sci. | pmid:23696608 |
| Sharma A et al. | Trichostatin a inhibits corneal haze in vitro and in vivo. | 2009 | Invest. Ophthalmol. Vis. Sci. | pmid:19168895 |
| Sonnemann J et al. | Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines. | 2005 | Invest New Drugs | pmid:15744585 |
| Fraczek J et al. | Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors. | 2009 | Invest New Drugs | pmid:18825314 |
| Li GC et al. | Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest. | 2006 | Int. J. Urol. | pmid:16771729 |
| Sah NK et al. | Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells. | 2006 | Int. J. Radiat. Oncol. Biol. Phys. | pmid:17011457 |
| Kim JH et al. | Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. | 2004 | Int. J. Radiat. Oncol. Biol. Phys. | pmid:15234053 |
| Kumar A et al. | γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines. | 2011 | Int. J. Radiat. Biol. | pmid:21815748 |
| Biade S et al. | Chemical agents that promote chromatin compaction radiosensitize tumour cells. | 2001 | Int. J. Radiat. Biol. | pmid:11682008 |
| Byers J and Eichinger D | Acetylation of the Entamoeba histone H4 N-terminal domain is influenced by short-chain fatty acids that enter trophozoites in a pH-dependent manner. | 2008 | Int. J. Parasitol. | pmid:17706222 |
| Takahashi K et al. | Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer. | 2006 | Int. J. Oncol. | pmid:16391785 |
| Bai T et al. | A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells. | 2006 | Int. J. Oncol. | pmid:16391806 |
| Hong X et al. | Heparanase expression is associated with histone modifications in glioblastoma. | 2012 | Int. J. Oncol. | pmid:22001963 |
| Kadaja-Saarepuu L et al. | Tumor suppressor p53 down-regulates expression of human leukocyte marker CD43 in non-hematopoietic tumor cells. | 2012 | Int. J. Oncol. | pmid:21947346 |
| You BR and Park WH | Trichostatin A induces apoptotic cell death of HeLa cells in a Bcl-2 and oxidative stress-dependent manner. | 2013 | Int. J. Oncol. | pmid:23165748 |
| Gray SG et al. | Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines. | 2004 | Int. J. Oncol. | pmid:15010814 |
| Sato K et al. | Deficient expression of the DPD gene is caused by epigenetic modification in biliary tract cancer cells, and induces high sensitivity to 5-FU treatment. | 2006 | Int. J. Oncol. | pmid:16820886 |
| Torres J et al. | Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas. | 2010 | Int. J. Oncol. | pmid:20811720 |
| Meng F et al. | Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3. | 2013 | Int. J. Oncol. | pmid:23709006 |
| Zhou C et al. | Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. | 2006 | Int. J. Oncol. | pmid:16773209 |
| Gahr S et al. | The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. | 2007 | Int. J. Oncol. | pmid:17671683 |
| Yee SB et al. | Trichostatin A induces apoptosis of p815 mastocytoma cells in histone acetylation- and mitochondria-dependent fashion. | 2004 | Int. J. Oncol. | pmid:15492835 |
| Al-Nakhle H et al. | Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region. | 2013 | Int. J. Oncol. | pmid:24068253 |
| Yamanegi K et al. | Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells. | 2015 | Int. J. Oncol. | pmid:25778932 |
| Kang KA et al. | Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity. | 2013 | Int. J. Oncol. | pmid:24100442 |
| Meli M et al. | Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells. | 2011 | Int. J. Oncol. | pmid:21318222 |
| Imesch P et al. | MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. | 2009 | Int. J. Oncol. | pmid:19639184 |
| Fortson WS et al. | Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells. | 2011 | Int. J. Oncol. | pmid:21519790 |
| Thelen P et al. | Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells. | 2004 | Int. J. Oncol. | pmid:14654937 |
| Li QQ et al. | Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach. | 2016 | Int. J. Oncol. | pmid:27082124 |
| Komata T et al. | Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells. | 2005 | Int. J. Oncol. | pmid:15809727 |
| Rho JH et al. | Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation. | 2005 | Int. J. Oncol. | pmid:16010429 |
| Choi YH | Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. | 2005 | Int. J. Oncol. | pmid:16010430 |
| Noro R et al. | PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors. | 2007 | Int. J. Oncol. | pmid:17912443 |
| Svechnikova I et al. | HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin. | 2008 | Int. J. Oncol. | pmid:18360709 |
| Asgar MA et al. | Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines. | 2016 | Int. J. Oncol. | pmid:26575528 |
| Stapnes C et al. | Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors. | 2007 | Int. J. Oncol. | pmid:17982680 |
| Carlisi D et al. | Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects. | 2008 | Int. J. Oncol. | pmid:18097557 |
| Park WH et al. | Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. | 2003 | Int. J. Oncol. | pmid:12684681 |
| Sonnemann J et al. | Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. | 2006 | Int. J. Oncol. | pmid:16465382 |
| Lee EJ et al. | Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells. | 2008 | Int. J. Oncol. | pmid:18813790 |
| Ma XH et al. | Neuroprotective capabilities of TSA against cerebral ischemia/reperfusion injury via PI3K/Akt signaling pathway in rats. | 2015 | Int. J. Neurosci. | pmid:24730998 |
| Qiang M et al. | Epigenetic mechanisms are involved in the regulation of ethanol consumption in mice. | 2014 | Int. J. Neuropsychopharmacol. | pmid:25522411 |
| Sakharkar AJ et al. | Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. | 2014 | Int. J. Neuropsychopharmacol. | pmid:24528596 |
| Inoue H et al. | Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis. | 2002 | Int. J. Mol. Med. | pmid:11956660 |
| Sachs LM et al. | An essential role of histone deacetylases in postembryonic organ transformations in Xenopus laevis. | 2001 | Int. J. Mol. Med. | pmid:11712071 |
| Ma J et al. | Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer. | 2012 | Int. J. Mol. Med. | pmid:22992863 |
| Gray SG et al. | Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma. | 2000 | Int. J. Mol. Med. | pmid:10601571 |
| Shi Y et al. | Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs. | 2018 | Int. J. Mol. Med. | pmid:29620153 |
| Andoh A et al. | Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells. | 2000 | Int. J. Mol. Med. | pmid:10851266 |
| Guo Y et al. | Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway. | 2017 | Int. J. Mol. Med. | pmid:28849190 |